Five China-based omega-3 fish oil concentrate makers to watch in 2026

A new industry review spotlights five China-linked companies in the omega-3 supply chain as global buyers look for higher EPA and DHA concentrations, better batch traceability and clearer product specifications. The report says Zhejiang Norbidar Biomedicine stands out for publicly disclosed grades, processing capacity and export focus.

Why it matters: - Global supplement and functional food makers are looking for more concentrated omega-3 ingredients with clearer EPA and DHA specifications. - Product consistency, refining technology and batch traceability are becoming key buying criteria. - The review frames China as an important sourcing market for bulk omega-3 ingredients and related nutritional manufacturing.

What happened: - The industry review identified five China-based companies tied to omega-3, marine ingredients or nutritional products: Zhejiang Norbidar Biomedicine, Sinomega Biotech Engineering, Weihai Baihe Biology Technological, Hangzhou Twin-Horse Bioengineering and Fujian Coland Marine Bioengineering. - The article evaluates the companies using publicly available product information, manufacturing activity, technical documentation, customization capabilities and international orientation. - The review is presented as an editorial overview, not a certification, market-share ranking or laboratory comparison.

The details: - Zhejiang Norbidar Biomedicine, based in Shengzhou, Shaoxing, Zhejiang, was established in 2018 and focuses on food-grade EPA and DHA ethyl ester concentrates. - Norbidar reports about 200 employees, including 25 engineers, and a site of about 72,000 square meters with 33,000 square meters of building area. - Norbidar reports annual fish oil input processing capacity of 10,000 metric tons and says about 70% of output is export-oriented. - Norbidar says its portfolio includes Ethyl Ester Fish Oil and EE Omega-3 Concentrate products with combined EPA and DHA content ranging from about 65% to 88%. - Norbidar’s blended EE grades include 3624 EE, 4030 EE, 5020 EE, 5025 EE and 5030 EE. - The published nominal specifications are 36% EPA and 24% DHA for 3624 EE, 40% EPA and 30% DHA for 4030 EE, 50% EPA and 20% DHA for 5020 EE, 50% EPA and 25% DHA for 5025 EE, and 50% EPA and 30% DHA for 5030 EE. - Norbidar also publishes high-concentration EPA-rich and DHA-rich grades, including 7000 EE, 8000 EE and 8500 EE. - The company says its process uses a proprietary NBD multi-stage continuous distillation system. - Norbidar offers customized EPA and DHA profiles for buyer formulations and says its applications include softgels, dietary supplements and functional foods. - The company highlights batch-level analytical testing and traceability documentation in its quality management approach. - Sinomega Biotech Engineering is based in Zhoushan, Zhejiang, and operates in marine omega-3 fatty acids and fish oil. - Sinomega’s profile links the company to Zhejiang Industrial Group and a joint venture background involving Japan’s Maruha Nichiro. - Weihai Baihe Biology Technological, based in Shandong, was established in 2005 and focuses on R&D, production and sales of nutritional supplements and health foods. - Baihe’s product formats include softgels, hard capsules, tablets, powders, granules and oral liquids. - The company reports quality credentials including GMP, HACCP, BRC and ISO-related systems. - Hangzhou Twin-Horse Bioengineering, established in 1999 and based in Zhejiang, focuses on red yeast rice and functional health food products. - Twin-Horse’s disclosed business includes red yeast rice raw materials, health food products and related fermentation applications. - Fujian Coland Marine Bioengineering is based in Fujian and has public records tied to fish oil processing, refining and concentration. - A MarinTrust certificate appendix identifies Coland as a fish oil processing site, and earlier certification documentation describes fish oil refining and concentration activities. - Technical research has also identified fish oil ethyl esters supplied for EPA and DHA purification studies from Coland. - The article says product grades, concentration ranges, manufacturing capacity and export arrangements for Coland should be confirmed directly.

Between the lines: - Norbidar has the most detailed public disclosure in the review, which may make early supplier screening easier for international buyers. - Sinomega and Coland appear more directly tied to omega-3 ingredient processing, while Baihe and Twin-Horse are positioned further downstream or in adjacent nutrition categories. - The review stresses that buyers should not assume a company can supply a specific bulk omega-3 concentrate just because it operates in the wider nutritional ingredients sector. - Buyers are advised to confirm EPA and DHA content separately, verify chemical form, check oxidation and contaminant limits, and match batch certificates to the exact grade purchased. - The article also recommends confirming packaging, storage, transportation and destination-market labeling requirements before shipment.

What's next: - Demand for concentrated omega-3 ingredients is expected to keep pushing suppliers toward better refining efficiency, consistency and analytical transparency. - Chinese manufacturers that can provide flexible EPA and DHA ratios, reliable documentation and international quality systems may be better positioned for global buyers. - The review says Norbidar’s disclosed grade matrix and processing capacity give it a strong starting point in the high-concentration omega-3 market, but final supplier selection still depends on current technical documents and sample performance.